MyNEXtCARE App becomes a useful tool against COVID-19
With the rapid spread of the novel coronavirus, a large number of NEXtCARE members are now opting for video consultations through the Teleconsultation feature in their MyNEXtCARE app. The company was the first to launch this service in 2019. The consultations are provided by Health at Hand – a DHA licensed telehealth service provider with qualified doctors who speak English, Hindi and Arabic.
The teleconsultation feature helps members in Dubai and Northern Emirates to seek professional medical care from the safety of their home, without co-participation. Members can access the service without “out of pocket” through a quick registration on MyNEXtCARE app or the web version and are connected to a trusted licensed doctor within 2 minutes. Apart from that, members can also request refill medications for 3 months through the service. Dubai members are able to get prescription medicine delivered to them within 60 minutes, or even have lab test requests issued through the app.
“In line with the Government’s efforts to keep people safe, we encourage our members to use the Teleconsultation service,” says NEXtCARE CEO, Christian Gregorowicz. “The government as well as insurance companies have shown great support related to e-solutions in these challenging times”.
“The use case for telehealth has changed overnight with the emergence of the pandemic. Our teleconsultation platform was built for scale, which has allowed us to move quickly to support the community.” Commented Health at Hand’s Founder and CEO, Charlie Barlow.
With the pandemic keeping people in their homes, the Teleconsultation service has experienced a large volume of video calls through MyNEXtCARE app which has led to an 8.5% utilization rate for some groups of clients. NEXtCARE were quick to respond to the change in the market and supporting government mandate by making the Teleconsultation available overnight to 800,000 members.
MyNEXtCARE app can be downloaded from Google Play, App Store and Huawei AppGallery.